Trials / Recruiting
RecruitingNCT03647098
Survival Outcomes of Lung Cancer
Survival Outcomes for Lung Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20,000 (estimated)
- Sponsor
- Hunan Province Tumor Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective study to analyze the survival outcomes of different groups about lung cancer patients.
Detailed description
This study aims to analyze the survival outcomes of different groups about lung cancer patients. All the groups were assessed to the treatment decisions guided by molecular profiling and clinical judgment of principal investigators
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Treatment | Treatment decisions guided by molecular profiling and clinical judgment of principal investigators |
Timeline
- Start date
- 2018-08-01
- Primary completion
- 2028-12-31
- Completion
- 2030-12-31
- First posted
- 2018-08-27
- Last updated
- 2025-02-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03647098. Inclusion in this directory is not an endorsement.